Juul Labs reaches $438.5 million settlement in youth marketing probe


Juul Labs has reached a tentative agreement to pay $438.5 million to a number of states investigating the company's sales and marketing practices, including its efforts to appeal to children and its contribution to the teenage vaping crisis, multiple outlets reported Tuesday.
The probe, led by more than 30 states and territories, "found that the company appealed to young people by hiring young models, using social media to court teenagers, and giving out free samples," writes The New York Times.
"We think that this will go a long way in stemming the flow of youth vaping," said Connecticut Attorney General William Tong, who led negotiations for multiple parties in the probe, per The Washington Post. "We are under no illusions and cannot claim that it will stop youth vaping. ... But we have essentially taken a big chunk out of what was once a market leader."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Per the deal, Juul will now "refrain from all youth marketing, paid product placement, advertising on public transportation, funding education programs, [and] depicting anyone under 35 years old in advertisements or using cartoons in ads, among other marketing activities," Bloomberg summarizes, per a statement from Tong. The company also agreed not to advertise on billboards or use paid influencer promotions in its marketing.
Juul, meanwhile, called the settlement "a significant part of our ongoing commitment to resolve issues from the past" — though it said it was not admitting to any wrongdoing, per the Times.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
May 31 editorial cartoons
Cartoons Saturday's political cartoons include how much to pay for a pardon, medical advice from a brain worm, and a simple solution to the national debt.
-
5 costly cartoons about the national debt
Cartoons Political cartoonists take on the USA's financial hole, rare bipartisan agreement, and Donald Trump and Mike Johnson.
-
Green goddess salad recipe
The Week Recommends Avocado can be the creamy star of the show in this fresh, sharp salad
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows